Ipshita Nandi
Overview
Explore the profile of Ipshita Nandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nandi I, Ji L, Smith H, Avizonis D, Papavasiliou V, Lavoie C, et al.
Nat Commun
. 2024 Aug;
15(1):6587.
PMID: 39097623
Metabolic reprogramming, a hallmark of tumorigenesis, involves alterations in glucose and fatty acid metabolism. Here, we investigate the role of Carnitine palmitoyl transferase 1a (Cpt1a), a key enzyme in long-chain...
2.
Nandi I, Smith H, Sanguin-Gendreau V, Ji L, Pacis A, Papavasiliou V, et al.
J Clin Invest
. 2023 Feb;
133(7).
PMID: 36795481
Activation of the tyrosine kinase c-Src promotes breast cancer progression and poor outcomes, yet the underlying mechanisms are incompletely understood. Here, we have shown that deletion of c-Src in a...
3.
Mohammad A, Kim S, Bertos N, El-Assaad W, Nandi I, Smith H, et al.
Mol Cancer Res
. 2020 Jun;
18(10):1477-1490.
PMID: 32587106
PTEN loss-of-function contributes to hyperactivation of the PI3K pathway and to drug resistance in breast cancer. Unchecked PI3K pathway signaling increases activation of the mechanistic target of rapamycin complex 1...
4.
Smith H, Hirukawa A, Sanguin-Gendreau V, Nandi I, Dufour C, Zuo D, et al.
Nat Commun
. 2019 Jul;
10(1):2901.
PMID: 31263101
Dysregulation of histone modifications promotes carcinogenesis by altering transcription. Breast cancers frequently overexpress the histone methyltransferase EZH2, the catalytic subunit of Polycomb Repressor Complex 2 (PRC2). However, the role of...